What is diabetes.
This pathway can be summarized as follows: ghrelin GHS-R Ca2+ CaMKK2 AMPK ACC CPT1 (ROS UCP2) / ceramide NPY/AgRP neurons and POMC neurons [29](Fig
Semaglutide GLP-1 is also a highly effective option for weight loss among eligible patients to help avoid obesity-related complications
For the LEAD-2 Study Group Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: The LEAD (liraglutide effect and action in diabetes)-2 study
In Summary To summarise briefly what has been covered in this blog post: Incretin-based therapeutics are changing the treatment landscape in many diseases such as diabetes, obesity, as well as in organs like the heart, liver, kidneys and brain Tools and biomarkers (like imaging) can provide helpful insights to further our understanding of how incretins work The future for incretin-based therapies is bright with options for novel combinations and expansion into new indications and disease areas Blog disclaimer The views and opinions expressed in this article are solely those of the contributing author/s
Gut and Liver, 14(2), 153-167
